Company: NDRA
Filing Date: 2025-11-06
Form Type: S-3
Source: 0001213900-25-107232
Chunk: 45

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-06
Form: S-3
Chunk 45
---
 and the purchasers party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on October 15, 2025). |
| 10.2    |     | Form of Registration Rights Agreement by and between ENDRA Life Sciences Inc. and the purchasers party thereto (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed with the SEC on October 15, 2025).                 |
| 23.1*   |     | Consent of RBSM LLP, Independent Registered Public Accounting Firm.                                                                                                                                                                                             |
| 23.2*   |     | Consent of K&L Gates LLP (included as part of Exhibit 5.1).                                                                                                                                                                                                     |
| 24.1*   |     | Power of Attorney (included on signature page).                                                                                                                                                                                                                 |
| 107*    |     | Filing Fee Table.                                                                                                                                                                                                                                               |

| * | Filed herewith |

<div align='center'>II-3</div>

Item 17. Undertakings.

The undersigned registrant
hereby undertakes:

| (a) | (1) To file, during any period in                                                                
 which offers or sales are being made, a post-effective amendment to this registration statement: |

| (i) | to include any prospectus required by section 
 10(a)(3) of the Securities Act of 1933;       |

| (ii) | to reflect in the prospectus any facts                                                             
 or events arising after the effective date of the registration statement (or the most recent       
 post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental 
 change in the information set forth in the registration statement. Notwithstanding the foregoing,  
 an increase or decrease in volume of securities offered (if the total dollar value of securities   
 offered would not exceed that which was registered) and any deviation from the low or high         
 end of the estimated maximum offering range may be reflected in the form of prospectus filed       
 with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and        
 price represent no more than a 20% change in the maximum aggregate offering price set forth        
 in the “Calculation of Registration Fee” table in the effective registration                       
 statement;                                                                                         |

| (iii) | to include any material information with                                                             
 respect to the plan of distribution not